Curated News: NEJM

Filters close
access_time Embargo lifts in 2 days
This news release is embargoed until 18-Sep-2024 5:00 PM EDT Released to reporters: 13-Sep-2024 10:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Avian flu found in wastewater of 10 Texas cities through virome sequencing by researchers at UTHealth Houston and Baylor College of Medicine
Released: 11-Sep-2024 5:05 PM EDT
Avian flu found in wastewater of 10 Texas cities through virome sequencing by researchers at UTHealth Houston and Baylor College of Medicine
University of Texas Health Science Center at Houston

Avian influenza A(H5N1) virus, which spread to cattle and infected 14 people this year, was detected using virome sequencing in the wastewater of 10 Texas cities by researchers at UTHealth Houston and Baylor College of Medicine.

Newswise:Video Embedded new-brain-computer-interface-allows-man-with-als-to-speak-again
VIDEO
Released: 14-Aug-2024 4:05 PM EDT
New brain-computer interface allows man with ALS to ‘speak’ again
UC Davis Health

A brain-computer interface developed by UC Davis Health accurately translates brain signals into speech. The device implanted in the brain of a man with ALS is the most accurate system of its kind.

Newswise: FDA Approves Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation
Released: 7-Aug-2024 9:05 AM EDT
FDA Approves Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation
Johns Hopkins Medicine

A new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma, was approved Aug. 6 by the U.S. Food and Drug Administration (FDA). The promising new drug stems from a 2008 genetic discovery made at the Johns Hopkins Kimmel Cancer Center.

Newswise: MIMI_KIM_2015.JPG?h=09daaa4d&itok=KBVpacQ_
Released: 30-Jul-2024 9:05 AM EDT
Phase 3 Clinical Trial Shows Benefits of a New Treatment for Children With Congenital Adrenal Hyperplasia
Children's Hospital Los Angeles

When it comes to caring for children with congenital adrenal hyperplasia (CAH), avoiding the side effects of traditional treatments has long been a challenge. But in a recent phase 3 clinical trial, a new drug called crinecerfont showed safety and efficacy in children with classic CAH, the severe form of this condition.

Released: 29-Jul-2024 11:05 AM EDT
Nueva investigación descubre una nueva combinación de terapia para personas con un tipo de leucemia, lo que les permite vivir más tiempo
Mayo Clinic

En un nuevo estudio multicéntrico internacional dirigido por el Centro Oncológico Integral de Mayo Clinic, investigadores encontraron que las personas con el subtipo de leucemia linfoblástica aguda precursores de células B (LLA-BCP), que tampoco presentaban una anomalía genética conocida como cromosoma Filadelfia y que estaban en remisión y sin rastros de cáncer, mostraron tasas de supervivencia significativamente más altas cuando se agregó blinatumomab al tratamiento de quimioterapia.

Released: 29-Jul-2024 11:05 AM EDT
بحث جديد يكتشف مزيجًا علاجيًا للمصابين بأحد أنواع ابيضاض الدم (لُوكيميا) يطيل بقائهم على قيد الحياة
Mayo Clinic

في دراسة دولية جديدة متعددة المراكز بقيادة مركز مايو كلينك الشامل للسرطان، وجد الباحثون أن الأشخاص المصابين بالنوع الفرعي من سلائف الخلايا البائية من ابيضاض الدم (لُوكيميا) بالأرومات اللِّمفاوية الحادّ، والذين أيضًا كانوا يفتقرون إلى خلل وراثي يعرف باسم كروموسوم فيلادلفيا وكانوا في فترة هدأة دون أي أثر للسرطان، أظهروا معدلات بقاء على قيد الحياة أعلى بشكل ملحوظ عندما أُضيف بليناتوموماب إلى علاجهم الكيميائي. تُنشر نتائج الدراسة العشوائية هذا الشهر في مجلة نيو إنجلاند الطبية (The New England Journal of Medicine).

Released: 29-Jul-2024 11:05 AM EDT
Nova pesquisa descobre uma nova combinação de terapia para pessoas com um tipo de leucemia, permitindo que elas vivam mais
Mayo Clinic

Em um novo estudo multicêntrico internacional liderado pelo Centro Oncológico Integral da Mayo Clinic, pesquisadores descobriram que pessoas com o subtipo de leucemia linfoblástica aguda de precursor de células B (LLA-BCP), que também não apresentavam uma anomalia genética conhecida como cromossomo Filadélfia e que estavam em remissão e sem vestígios de câncer, mostraram taxas de sobrevivência significativamente mais elevadas quando o blinatumomab foi adicionado ao tratamento quimioterápico.

Released: 24-Jul-2024 5:05 PM EDT
New research discovers a new combination of therapy for people with a type of leukemia, leading them to live longer
Mayo Clinic

In a new multicenter international study led by the Mayo Clinic Comprehensive Cancer Center, researchers found that people with the B-cell precursor subtype of acute lymphoblastic leukemia (BCP-ALL), who also lacked a genetic abnormality known as the Philadelphia chromosome and were in remission with no trace of cancer, showed significantly higher survival rates when blinatumomab was added to their chemotherapy treatment.

19-Jul-2024 10:00 AM EDT
Decoding Early Lyme Disease
Rutgers University-New Brunswick

A Rutgers Health physician-scientist publishes guidance for primary care doctors diagnosing and treating early Lyme disease, a bacterial infection

Newswise: Risk of long COVID declined over course of pandemic
15-Jul-2024 2:05 PM EDT
Risk of long COVID declined over course of pandemic
Washington University in St. Louis

The risk of long COVID has declined over the course of the pandemic, although it remains a persistent threat. Researchers from Washington University School of Medicine in St. Louis identified vaccination as a primary factor in reducing the risk of long COVID.

Newswise: George Bakris, internationally recognized hypertension expert, 1952-2024
Released: 11-Jul-2024 5:05 PM EDT
George Bakris, internationally recognized hypertension expert, 1952-2024
University of Chicago Medical Center

Bakris served on the UChicago faculty for 18 years and was director of the Comprehensive Hypertension Center.

Newswise: 1920_ai-chat-image-cedars-sinai.jpg?10000
Released: 11-Jul-2024 11:05 AM EDT
Cedars-Sinai AI Expert Makes Case for Importance of Thoughtful Model Design
Cedars-Sinai

The data fed to artificial intelligence (AI) systems make all the difference on performance, according to David Ouyang, MD, a cardiologist in the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai.

Newswise: Electroconvulsive therapy or ketamine? Clinical factors affect outcomes
Released: 25-Jun-2024 11:05 AM EDT
Electroconvulsive therapy or ketamine? Clinical factors affect outcomes
UT Southwestern Medical Center

Patients with moderate to severe treatment-resistant depression (TRD) might have better symptom relief from ketamine infusions than from electroconvulsive therapy (ECT), but those with severe TRD could benefit more from ECT early in treatment, an analysis led by a UT Southwestern Medical Center researcher shows. The findings, published in JAMA Network Open, are the first to identify characteristics that distinguish which treatments might benefit TRD patients more.

Newswise: Study Identifies First Drug Therapy for Sleep Apnea
18-Jun-2024 1:05 PM EDT
Study Identifies First Drug Therapy for Sleep Apnea
UC San Diego Health

UC San Diego School of Medicine international study shows new drug improves sleep, health in patients diagnosed with obesity and sleep apnea.

Newswise: Global trial confirms benefit of antacids on bleeding prevention for ventilated patients
12-Jun-2024 12:05 PM EDT
Global trial confirms benefit of antacids on bleeding prevention for ventilated patients
McMaster University

Critically ill patients are at risk of stress-induced upper gastrointestinal bleeding. Now, a global trial led by McMaster University researchers confirms that a widely available drug does prevent upper gastrointestinal bleeding.

10-Jun-2024 4:05 PM EDT
Multicenter Randomized Trial Identifies Method of Preoxygenation That Prevents Hypoxemia and Cardiac Arrest During Emergency Tracheal Intubation
Vanderbilt University Medical Center

Vanderbilt University Medical Center (VUMC) led the Department of the Defense-funded Pragmatic Trial Examining Oxygenation Prior to Intubation PREOXI study comparing the two most commonly used methods used to preoxygenate patients prior to tracheal intubation: preoxygenation with noninvasive ventilation and preoxygenation with an oxygen mask.

7-Jun-2024 10:05 AM EDT
Case study reveals important new details about rare second cancers related to CAR-T therapy
Georgetown University Medical Center

A new detailed analysis of a patient’s second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance for oncologists and pathologists about the clinical presentation and pathologic features involved in a CAR-T related second cancer.

Newswise: Team tests strategies to care for patients with multiple diseases
Released: 11-Jun-2024 10:05 AM EDT
Team tests strategies to care for patients with multiple diseases
UT Southwestern Medical Center

In a large clinical trial, UT Southwestern Medical Center researchers developed a robust model for testing strategies to prevent health problems in patients with multiple chronic conditions.

Newswise: RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial
Released: 29-May-2024 5:30 AM EDT
RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial
Mount Sinai Health System

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.



close
1.9286